Ahn Hyung Jun 2024-02-21T05:06:46Z 2024-02-21T05:06:46Z 2019-07 - https://pubs.kist.re.kr/handle/201004/148837 7.9, KIST siRNA Cancer therapy virus non-viral vector ovarian cancer Alternative approaches for overcoming transient silencing effects of RNAi or drug resistance in chemoresistant cancers Book 2019 KIST Precision Nanosystems Joint Workshop